Takotsubo syndrome in patients with cancer treated with immune checkpoint inhibitors: a new adverse cardiac complication

Eur J Heart Fail. 2019 Jul;21(7):945-947. doi: 10.1002/ejhf.1497.

Stephane Ederhy¹, Charles Dolladille^{2

3}, Franck Thuny^{4

5

6}, Joachim Alexandre², Ariel Cohen¹

¹ Assistance Publique-Hôpitaux de Paris, Hôpital Saint Antoine, Department of Cardiology, Paris, France; INSERM U 856, Paris, France and UNICO APHP.6 Cardio-oncology Program.
² Department of Pharmacology, CHU Caen, PICARO Cardio-Oncology Programme, Caen, France.
³ EA 4650, Signalisation, Électrophysiologie et Imagerie des Lésions d'Ischémie-Reperfusion Myocardique, Normandie University, UNICAEN, Caen, France.
⁴ Mediterranean University Cardio-Oncology Centre (Medi-CO centre); Unit of Heart Failure and Valve Heart Diseases (UNIV); Department of Cardiology, Aix-Marseille University, Assistance Publique-Hôpitaux de Marseille, Nord Hospital, Marseille, France.
⁵ Centre for CardioVascular and Nutrition research (C2VN), Aix-Marseille University, Marseille, France.
⁶ Assistance Publique-Hôpitaux de Marseille, Oncosafety Network of the Early Phases Cancer Trials Center (CLIP2), Aix-Marseille University, Marseille, France.

No abstract available

Publication types